EHAB Stock Recent News

EHAB's investments in healthcare predictive analytics, expected to grow at 23%-24% CAGR, could significantly boost future net income growth. Restructuring, activism, and strategic reviews are potential catalysts for stock price appreciation, enhancing financial flexibility from 2025 to 2030. Despite recent negative net income, EHAB's consistent positive cash flow and undervaluation indicate substantial upside potential in stock price.

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, announced today that it is proud to be Certified™ by Great Place To Work®. This prestigious award is based entirely on the experiences of current employees working at Enhabit. This year, 83% of employees said it's a great place to work, which is 26 points higher than the average U.S. company. Great Place To Work® is the global authority on workplace culture, employee experience and leadership behavi.

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2024, on Nov. 6, 2024, and host a webcast and conference call on Nov. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Nov. 7, 2024 10 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Inte.

Enhabit, Inc. (NYSE:EHAB ) Q2 2024 Earnings Conference Call August 7, 2024 10:00 AM ET Company Participants Barb Jacobsmeyer - President & CEO Crissy Carlisle - CFO Conference Call Participants Noah Erni - Jefferies Ben Rossi - Citi A.J. Rice - UBS Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Operator Good morning, everyone, and welcome to Enhabit Home Health & Hospice's second quarter 2024 earnings conference call.

Enhabit (EHAB) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.04 per share a year ago.

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. “Crissy has made important contributions to Enhabit since we became a public.

Enhabit (EHAB) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Enhabit (EHAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Enhabit (EHAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.